SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001511164-11-000129
Filing Date
2011-12-21
Accepted
2011-12-21 13:04:39
Documents
7
Period of Report
2011-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A neurokineform10qaxbrlq2july3.htm 10-Q/A 30389
  Complete submission text file 0001511164-11-000129.txt   1115156

Data Files

Seq Description Document Type Size
2 EX-101 INSTANCE DOCUMENT neukf-20110731.xml EX-101.INS 160140
3 EX-101 SCHEMA DOCUMENT neukf-20110731.xsd EX-101.SCH 10004
4 EX-101 CALCULATION LINKBASE DOCUMENT neukf-20110731_cal.xml EX-101.CAL 5480
5 EX-101 DEFINITION LINKBASE DOCUMENT neukf-20110731_def.xml EX-101.DEF 39670
6 EX-101 LABELS LINKBASE DOCUMENT neukf-20110731_lab.xml EX-101.LAB 79157
7 EX-101 PRESENTATION LINKBASE DOCUMENT neukf-20110731_pre.xml EX-101.PRE 58263
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-Q/A | Act: 34 | File No.: 333-161157 | Film No.: 111273974
SIC: 2834 Pharmaceutical Preparations